CymaBay Announces Exclusive Licensing Agreement with Kowa Pharmaceuticals America, Inc. for the Development and Commercialization of Arhalofenate in the United States

World News: . []

NEWARK Calif Jan 03 2017 GLOBE NEWSWIRE -- LINK  Therapeutics Inc NasdaqCBAY a clinical-stage biopharmaceutical company developing therapies to treat LINK  and orphan diseases with high unmet LINK  need today announced that it has ...

More news and information about CymaBay Therapeutics, Inc.

Published By:

Globe Newswire: 21:01 GMT Tuesday 3rd January 2017

Published: .

Search for other references to "cymabay" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us